<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Asia</title>
	<atom:link href="http://www.bioscreening.net/category/news-by-region/asia/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Ancient Chinese cures translate into modern Western medicines</title>
		<link>http://www.bioscreening.net/2011/11/28/ancient-chinese-cures-translate-into-modern-western-medicines/</link>
		<comments>http://www.bioscreening.net/2011/11/28/ancient-chinese-cures-translate-into-modern-western-medicines/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 14:45:27 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Natural Products]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1357</guid>
		<description><![CDATA[The Chem-TCM is the most comprehensive database of its kind and translates more than 12,000 chemicals from more than 300 Chinese herbs used in traditional Chinese medicine (TCM) into Western terminology. &#8220;Future researchers will now be able to better understand the chemical basis of remedies that have been in use for thousands of years,&#8221; says [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/ancient-chinese-cures-translate-into-modern-western-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chemie Uzbekistan 2011</title>
		<link>http://www.bioscreening.net/2011/11/14/chemie-uzbekistan-2011/</link>
		<comments>http://www.bioscreening.net/2011/11/14/chemie-uzbekistan-2011/#comments</comments>
		<pubDate>Mon, 14 Nov 2011 18:18:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Agriculture Research]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1316</guid>
		<description><![CDATA[The 5th Anniversary Central Asian International exhibition «Chemical industry &#8211; Chemie Uzbekistan» and the 2nd Uzbek International exhibition of plastics and rubber &#8211; «Plastex Uzbekistan 2011» will be held from the 16th till the 18th of November 2011, at the Pavilion 1 of OJSS «Uzexpocentre». “ITE UZBEKISTAN” is the organizer of the exhibitions The exhibitions [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/14/chemie-uzbekistan-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ranbaxy to transfer drug discovery unit to Daiichi Sankyo</title>
		<link>http://www.bioscreening.net/2010/07/08/ranbaxy-to-transfer-drug-discovery-unit-to-daiichi-sankyo/</link>
		<comments>http://www.bioscreening.net/2010/07/08/ranbaxy-to-transfer-drug-discovery-unit-to-daiichi-sankyo/#comments</comments>
		<pubDate>Fri, 09 Jul 2010 02:54:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/08/ranbaxy-to-transfer-drug-discovery-unit-to-daiichi-sankyo/</guid>
		<description><![CDATA[Jul 06, 2010 (Datamonitor via COMTEX) &#8211; Daiichi Sankyo and Ranbaxy Laboratories, a research based pharmaceutical company, have announced that Ranbaxy&#8217;s new drug discovery research, or NDDR, has been transferred to Daiichi Sankyo India Pharma as part of the strategy to strengthen the global R&#038;D structure of the Daiichi Sankyo Group. The transaction has been [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/08/ranbaxy-to-transfer-drug-discovery-unit-to-daiichi-sankyo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Trials in Asia Summit 2009</title>
		<link>http://www.bioscreening.net/2009/05/10/clinical-trials-in-asia-summit-2009/</link>
		<comments>http://www.bioscreening.net/2009/05/10/clinical-trials-in-asia-summit-2009/#comments</comments>
		<pubDate>Mon, 11 May 2009 01:20:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/05/10/clinical-trials-in-asia-summit-2009/</guid>
		<description><![CDATA[Determining the prospective strategies for Implementing Clinical trials in India &#038; South Asia &#8211; Today&#8217;s Hottest Market 18th &#8211; 20th May 2009, The Park, New Delhi, India Â  Key Speakers â€¢ Chandrashekhar Potkar, Director, Medical and Regulatory Affairs, Pfizer, India â€¢ Viraj Rajadhyaksha, Senior Manager, Operations, Planning &#038; Mgmt Clinical Research, Pfizer, India â€¢ Rajesh [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/05/10/clinical-trials-in-asia-summit-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seegene Receives Approval from Health Canada for Its Respiratory Virus Multi-Pathogen Detection Tests</title>
		<link>http://www.bioscreening.net/2009/01/11/seegene-receives-approval-from-health-canada-for-its-respiratory-virus-multi-pathogen-detection-tests/</link>
		<comments>http://www.bioscreening.net/2009/01/11/seegene-receives-approval-from-health-canada-for-its-respiratory-virus-multi-pathogen-detection-tests/#comments</comments>
		<pubDate>Sun, 11 Jan 2009 21:52:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/01/11/seegene-receives-approval-from-health-canada-for-its-respiratory-virus-multi-pathogen-detection-tests/</guid>
		<description><![CDATA[Seegene Receives Approval from Health Canada for Its Respiratory Virus Multi-Pathogen Detection Tests Seeplex(R) RV5 and RV12 give Canadian caregivers an effective way to test for a broad range of respiratory viruses and pathogens in one single test. ROCKVILLE, Maryland and SEOUL, Korea, December 3, 2008 &#8212; Seegene, Inc., a leader in multi-pathogen diagnostic testing, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/01/11/seegene-receives-approval-from-health-canada-for-its-respiratory-virus-multi-pathogen-detection-tests/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio</title>
		<link>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/</link>
		<comments>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/#comments</comments>
		<pubDate>Tue, 09 Sep 2008 19:06:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/</guid>
		<description><![CDATA[Riyadh, Kingdom of Saudi Arabia &#8212; September 9, 2008 &#8212; An international consortium consisting of Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio have in a joint effort performed an initial sequencing and analysis of the first Arab human genome, as part of a large project to sequence 100 Arab human genomes to map [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AstraZeneca, Singapore institutions sign innovative new partnership to develop anti-cancer compounds</title>
		<link>http://www.bioscreening.net/2008/08/19/astrazeneca-singapore-institutions-sign-innovative-new-partnership-to-develop-anti-cancer-compounds/</link>
		<comments>http://www.bioscreening.net/2008/08/19/astrazeneca-singapore-institutions-sign-innovative-new-partnership-to-develop-anti-cancer-compounds/#comments</comments>
		<pubDate>Tue, 19 Aug 2008 19:19:25 +0000</pubDate>
		<dc:creator>Fred</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/08/19/astrazeneca-singapore-institutions-sign-innovative-new-partnership-to-develop-anti-cancer-compounds/</guid>
		<description><![CDATA[Healthcare company AstraZeneca Plc (AZN: News, Chart, Quote ,AZN.L: News, Chart, Quote ) said Friday that it signed an innovative new partnership with the National Cancer Centre Singapore, or NCCS, and the National University Hospital, or NUH, for development of anti-cancer compounds. The collaboration is spelt out in a Memorandum of Understanding, or MOU. As [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/08/19/astrazeneca-singapore-institutions-sign-innovative-new-partnership-to-develop-anti-cancer-compounds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution</title>
		<link>http://www.bioscreening.net/2008/07/28/seegene-and-shimadzu-agree-to-join-multi-pathogen-tests-and-platform-for-combined-analytics-solution/</link>
		<comments>http://www.bioscreening.net/2008/07/28/seegene-and-shimadzu-agree-to-join-multi-pathogen-tests-and-platform-for-combined-analytics-solution/#comments</comments>
		<pubDate>Mon, 28 Jul 2008 21:19:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/28/seegene-and-shimadzu-agree-to-join-multi-pathogen-tests-and-platform-for-combined-analytics-solution/</guid>
		<description><![CDATA[ROCKVILLE, MD and KYOTO, JAPAN&#8211;July 28, 2008 &#8211; Seegene, Inc. and Shimadzu Corporation today announced a strategic partnership to combine Seegene&#8217;s Seeplex(R) multi-pathogen tests with Shimadzu&#8217;s MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction-based tests with Shimadzu&#8217;s MultiNA high-speed electrophoresis system to [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/28/seegene-and-shimadzu-agree-to-join-multi-pathogen-tests-and-platform-for-combined-analytics-solution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beijing Genomics Institute signs global site license with CLC bio for Next Generation Sequencing software platform</title>
		<link>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/</link>
		<comments>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/#comments</comments>
		<pubDate>Fri, 18 Jul 2008 21:34:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/</guid>
		<description><![CDATA[Aarhus Denmark, July 3rd, 2008 â€“ Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio&#8217;s Next Generation Sequencing solution, CLC Genomics Workbench. The site license covers all researchers at all BGI sites, both inside and outside of China. Head of Bioinformatics Division at BGI, Ruiqiang Li states, â€œWe have chosen [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mumie &#8211; Description and Origin</title>
		<link>http://www.bioscreening.net/2008/04/25/mumie-description-and-origin/</link>
		<comments>http://www.bioscreening.net/2008/04/25/mumie-description-and-origin/#comments</comments>
		<pubDate>Fri, 25 Apr 2008 23:34:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Natural Products]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/04/25/mumie-description-and-origin/</guid>
		<description><![CDATA[Though Mumie has been used in folk medicine of different countries for almost two thousand years, there are still many legends regarding its mysterious origin. In Russia serious research has been conducted on Mumie since 1910. This research became even more intense during the past twenty years Government financing supported research that was conducted at [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/04/25/mumie-description-and-origin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Health Care&#8217;s Silent Spring</title>
		<link>http://www.bioscreening.net/2008/04/09/health-cares-silent-spring/</link>
		<comments>http://www.bioscreening.net/2008/04/09/health-cares-silent-spring/#comments</comments>
		<pubDate>Wed, 09 Apr 2008 15:50:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Biotech & Pharma Law]]></category>
		<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[North America]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/04/09/health-cares-silent-spring/</guid>
		<description><![CDATA[As the Intergovernmental Working Group (IGWG) of the WHO prepares to meet and discuss how to best facilitate the expropriation of intellectual property rights (in this case the IPR of pharmaceutical patents) it&#8217;s important to consider the unintended consequences &#8212; the death of medical innovation. The global purloiners of patents &#8212; led by Jamie Love [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/04/09/health-cares-silent-spring/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio provides bioinformatics educational solutions to Andhra University and 25 affiliated colleges</title>
		<link>http://www.bioscreening.net/2007/12/20/clc-bio-provides-bioinformatics-educational-solutions-to-andhra-university-and-25-affiliated-colleges/</link>
		<comments>http://www.bioscreening.net/2007/12/20/clc-bio-provides-bioinformatics-educational-solutions-to-andhra-university-and-25-affiliated-colleges/#comments</comments>
		<pubDate>Thu, 20 Dec 2007 18:42:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/12/20/clc-bio-provides-bioinformatics-educational-solutions-to-andhra-university-and-25-affiliated-colleges/</guid>
		<description><![CDATA[Visakhpatnam, Andhra Pradesh, India â€“ December 20, 2007 &#8212; CLC bio today announced the signing of a Memorandum of Understanding at an official ceremony at Andhra University, one of the most prestigious universities in India. Under the agreement, Andhra University and 25 affiliated post graduate colleges will implement CLC bioâ€™s educational solutions as an integrated [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/12/20/clc-bio-provides-bioinformatics-educational-solutions-to-andhra-university-and-25-affiliated-colleges/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Reducing the &#8216;what ifs&#8217; in drug discovery</title>
		<link>http://www.bioscreening.net/2007/10/25/reducing-the-what-ifs-in-drug-discovery/</link>
		<comments>http://www.bioscreening.net/2007/10/25/reducing-the-what-ifs-in-drug-discovery/#comments</comments>
		<pubDate>Thu, 25 Oct 2007 16:47:17 +0000</pubDate>
		<dc:creator>Fred</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/25/reducing-the-what-ifs-in-drug-discovery/</guid>
		<description><![CDATA[With emergence of specialised software applications, drug discovery has become a highly cost-competitive area for Indian pharma companies. Nagesh Joshi examines the use of specialised software applications in drug discovery Drug discovery was the main aim of any pharma company, prior to the advent of the doctrine that companies could have a profitable business model [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/25/reducing-the-what-ifs-in-drug-discovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Soya bean can help fight dreaded HIV, claims research</title>
		<link>http://www.bioscreening.net/2007/10/18/soya-bean-can-help-fight-dreaded-hiv-claims-research/</link>
		<comments>http://www.bioscreening.net/2007/10/18/soya-bean-can-help-fight-dreaded-hiv-claims-research/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:21:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/soya-bean-can-help-fight-dreaded-hiv-claims-research/</guid>
		<description><![CDATA[SOYA BEAN is packed with powerful punch. It not only has the power to absorb the heavy metals from the mother earth but also has the potential as a bio-fuel besides possessing the quality to fight the dreaded HIV. Realising the potential Naithani Plant Genetics Laboratory of Botany Department, Allahabad University (AU), has approached the [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/soya-bean-can-help-fight-dreaded-hiv-claims-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tikvah Therapeutics, Inc. And Chakra Biotech Pte. Ltd. Establish Collaboration To Accelerate The Development Of Novel Antipsychotic Compounds</title>
		<link>http://www.bioscreening.net/2007/09/11/tikvah-therapeutics-inc-and-chakra-biotech-pte-ltd-establish-collaboration-to-accelerate-the-development-of-novel-antipsychotic-compounds/</link>
		<comments>http://www.bioscreening.net/2007/09/11/tikvah-therapeutics-inc-and-chakra-biotech-pte-ltd-establish-collaboration-to-accelerate-the-development-of-novel-antipsychotic-compounds/#comments</comments>
		<pubDate>Tue, 11 Sep 2007 19:29:26 +0000</pubDate>
		<dc:creator>Fred</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/09/11/tikvah-therapeutics-inc-and-chakra-biotech-pte-ltd-establish-collaboration-to-accelerate-the-development-of-novel-antipsychotic-compounds/</guid>
		<description><![CDATA[SINGAPORE, Norway, Sept 6, 2007 &#8211; (Hugin via ACN Newswire) &#8211; ATLANTA and SINGAPORE, Sept. 6, 2007 (PRIME NEWSWIRE) &#8212; Tikvah Therapeutics, Inc., a biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, and Chakra Biotech Pte. Ltd., a drug discovery and development company focusing on central nervous system disorders, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/09/11/tikvah-therapeutics-inc-and-chakra-biotech-pte-ltd-establish-collaboration-to-accelerate-the-development-of-novel-antipsychotic-compounds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fluidigm Singapore launches Biomedical Product Development Centre</title>
		<link>http://www.bioscreening.net/2007/02/01/fluidigm-singapore-launches-biomedical-product-development-centre/</link>
		<comments>http://www.bioscreening.net/2007/02/01/fluidigm-singapore-launches-biomedical-product-development-centre/#comments</comments>
		<pubDate>Thu, 01 Feb 2007 22:47:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/02/01/fluidigm-singapore-launches-biomedical-product-development-centre/</guid>
		<description><![CDATA[Singapore R&#038;D center to develop life science instruments targeted for US$650 million market SINGAPORE, Feb. 1,Â 2007 &#8211; Fluidigm accelerates its R&#038;D and manufacturing activities in Singapore, through the launch of its new Biomedical Product Development Center. This center, a core part of Fluidigm&#8217;s worldwide R&#038;D organization, will be responsible for the full development of a [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/02/01/fluidigm-singapore-launches-biomedical-product-development-centre/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioServe Partners with Harvard and University of Michigan on Landmark Public Health Study</title>
		<link>http://www.bioscreening.net/2007/01/25/bioserve-partners-with-harvard-and-university-of-michigan-on-landmark-public-health-study/</link>
		<comments>http://www.bioscreening.net/2007/01/25/bioserve-partners-with-harvard-and-university-of-michigan-on-landmark-public-health-study/#comments</comments>
		<pubDate>Fri, 26 Jan 2007 00:18:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/01/25/bioserve-partners-with-harvard-and-university-of-michigan-on-landmark-public-health-study/</guid>
		<description><![CDATA[Genetic Study to Understand Linkage Between Lead Exposure and Childrenâ€™s Intellectual Development in India; Possible Model for Broader Gene/Environment/Health Research Â  Laurel, MD, January 24, 2007 &#8212; BioServe, a leading provider of rapid, economical processing and analyses of genomic content from biological samples, has been selected to work with scientists from the Harvard and University [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/01/25/bioserve-partners-with-harvard-and-university-of-michigan-on-landmark-public-health-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Japanâ€™s NIHS Licenses Simulations Plus ClassPharmer Software for Five Years</title>
		<link>http://www.bioscreening.net/2006/10/05/japan%e2%80%99s-nihs-licenses-simulations-plus-classpharmer-software-for-five-years/</link>
		<comments>http://www.bioscreening.net/2006/10/05/japan%e2%80%99s-nihs-licenses-simulations-plus-classpharmer-software-for-five-years/#comments</comments>
		<pubDate>Thu, 05 Oct 2006 19:30:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/10/05/japan%e2%80%99s-nihs-licenses-simulations-plus-classpharmer-software-for-five-years/</guid>
		<description><![CDATA[National Institute of Health Sciences is Equivalent to U.S. F.D.A. LANCASTER, Calif.&#8211;(BUSINESS WIRE)&#8211;Simulations Plus, Inc. (AMEX:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has received a purchase order for a 5-year license for its ClassPharmerâ„¢ software for the National Institute of Health Sciences (NIHS) in [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/10/05/japan%e2%80%99s-nihs-licenses-simulations-plus-classpharmer-software-for-five-years/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Institut Pasteur Korea Selects ActivityBaseâ„¢ as its Screening Solution of Choice</title>
		<link>http://www.bioscreening.net/2006/10/05/institut-pasteur-korea-selects-activitybase%e2%84%a2-as-its-screening-solution-of-choice/</link>
		<comments>http://www.bioscreening.net/2006/10/05/institut-pasteur-korea-selects-activitybase%e2%84%a2-as-its-screening-solution-of-choice/#comments</comments>
		<pubDate>Thu, 05 Oct 2006 18:37:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/10/05/institut-pasteur-korea-selects-activitybase%e2%84%a2-as-its-screening-solution-of-choice/</guid>
		<description><![CDATA[IDBSÂ has announced thatÂ Institut Pasteur &#8211; Korea has implemented the ActivityBase data management software suite to increase efficiency and throughput in its screening operations. Institut Pasteur Korea (IP-K), a Research Center located in Seoul, South Korea, has purchased ActivityBase to handle their biology and chemistry data for High Throughput and High Content Screening (HTS/HCS). IP-K is [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/10/05/institut-pasteur-korea-selects-activitybase%e2%84%a2-as-its-screening-solution-of-choice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Peer-Reviewed Data Published in Toxicology in Vitro Shows Efficiency and Accuracy of Gene Expression Assay Technology</title>
		<link>http://www.bioscreening.net/2006/10/05/new-peer-reviewed-data-published-in-toxicology-in-vitro-shows-efficiency-and-accuracy-of-gene-expression-assay-technology/</link>
		<comments>http://www.bioscreening.net/2006/10/05/new-peer-reviewed-data-published-in-toxicology-in-vitro-shows-efficiency-and-accuracy-of-gene-expression-assay-technology/#comments</comments>
		<pubDate>Thu, 05 Oct 2006 18:26:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/10/05/new-peer-reviewed-data-published-in-toxicology-in-vitro-shows-efficiency-and-accuracy-of-gene-expression-assay-technology/</guid>
		<description><![CDATA[BIOWIRE HTG Inc., a provider of novel array-based gene expression assay technology and services for the life sciences industry, today announced results from a study measuring gene expression on marker genes have been published in the August 2006 issue of Toxicology in Vitro. The study examined the feasibility of obtaining higher throughput results using the [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/10/05/new-peer-reviewed-data-published-in-toxicology-in-vitro-shows-efficiency-and-accuracy-of-gene-expression-assay-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

